Elvira Bramon

Has grant

Professor of Neuroscience and Mental Health

University College London

United Kingdom

Research Interests

Explore related searches

Professors in United Kingdom

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

About

Elvira Bramon is a Professor of Neuroscience and Mental Health at University College London, UK. Her research focuses on the intersection of mental health and physical health in severe mental illness, specifically examining pharmacogenetics and its implications for treatment outcomes. Recent studies include investigations into the role of CYP gene variations in antipsychotic effects, lipid parameters, and cardiovascular disease risk factors associated with severe mental illness.

Recent Grants

Grant: Close

UCL Application for a Mental Health Data Pathfinder award

Open Date: 2018-03-30

Close Date: 2021-05-30

Grant: Close

Pharmacogenetics of antipsychotic drugs: Precision medicine for severe mental disorders.

Open Date: 2017-09-24

Close Date: 2021-09-23

Grant: Close

Homeostatic Plasticity in Psychosis-related Copy Number Variation

Open Date: 2016-09-25

Close Date: 2021-03-29

Grant: Close

Low coverage sequencing for the detection and analysis of genomic structural variants in schizophrenia

Open Date: 2011-12-01

Close Date: 2015-03-29

Grant: Close

Genetics of psychosis and its characteristic endophenotypes

Open Date: 2010-04-30

Close Date: 2015-08-30

Articles (13)

Year:

2025

Year:

2025

Year:

2025

Year:

2023

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2021

Year:

2021

Year:

2021

Year:

2020

Collaborators (27)

Sarah-Jayne Blakemore

Professor of Psychology and Cognitive Neuroscience

University of Cambridge

UNITED KINGDOM

Elvira Bramon

Research Interests

Explore related searches

Contact this professor

About

Recent Grants

Articles (13)

Characteristics of people with severe mental illness excluded from incentivised physical health checks in the UK: electronic healthcare record study

Prevalence and patient characteristics associated with cardiovascular disease risk factor screening in UK primary care for people with severe mental illness: an electronic healthcare record study

Effect of <i>CYP1A2</i>, <i>CYP2D6</i>, and <i>CYP3A4</i> Variation on Antipsychotic Treatment Outcomes

Associations of antidepressants and antipsychotics with lipid parameters: Do CYP2C19/CYP2D6 genes play a role? A UK population-based study

Neurophysiology in psychosis: The quest for disease biomarkers

Adolescent Verbal Memory as a Psychosis Endophenotype: A Genome-Wide Association Study in an Ancestrally Diverse Sample

Reward Processing in Children With Psychotic-Like Experiences

CARDIOMETABOLIC ABNORMALITIES IN SCHIZOPHRE-NIA. CAUSE OR CONSEQUENCE?

CYP2D6 Genetic Variation and Antipsychotic-Induced Weight Gain: A Systematic Review and Meta-Analysis

A Comparison of Ten Polygenic Score Methods for Psychiatric Disorders Applied Across Multiple Cohorts

The Influence of CYP2D6 and CYP2C19 Genetic Variation on Diabetes Mellitus Risk in People Taking Antidepressants and Antipsychotics

Postictal Psychosis in Epilepsy: A Clinicogenetic Study.

Intelligence, educational attainment, and brain structure in those at familial high-risk for schizophrenia or bipolar disorder.

Collaborators (27)

Sarah-Jayne Blakemore

Bruce Guthrie

Sang hyuck Lee

Sang Hong Lee

Ingrid Agartz

Robert Stewart

Donald Black

Eske Derks

Martin Alda

Robert Freedman

Baihan Wang

Tomas Hajek

Cheryl Olman

Matthew Kempton

Naomi Launders

Aurora Bonvino

Ann John

Johan H Thygesen

Elizabeth Buimer

Dale Nyholt

Machteld Marcelis

Henriette Buttenschøn

Sonja de Zwarte

John Powell

Lucía Colodro Conde

Bryan Mowry

David Osborn PhD FRCPsych

Make your next move.